Knowledge, attitude, and practice in pharmacovigilance and adverse drug reaction reporting among community pharmacists in Erbil city
Copyright (c) 2025 Lezan Sabah Ali, Prof. Dr. Samir Mahmood Othman (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- Articles
- Submited: March 4, 2025
-
Published: December 22, 2025
Abstract
Background and objective: Pharmacovigilance and adverse drug reaction (ADR) reporting are crucial for safeguarding medication safety. Community pharmacists play a vital role in the identification and reporting of ADRs. The objective of this study is to evaluate the knowledge, attitude, and practice of community pharmacists in Erbil city about pharmacovigilance and ADR reporting.
Methods: A cross-sectional study was carried out utilizing a structured, interviewer-administered questionnaire that involved a sample of 350 community pharmacists via convenience sampling method. The questionnaire collected demographic data and the pharmacist's knowledge, attitude, and practice toward pharmacovigilance and ADR reporting. SPSS was used for data entry and analysis.
Results: Among the participants, 47.4% displayed poor knowledge, 46.6% exhibited moderate knowledge, and merely 6% demonstrated a good knowledge. More than half of the participants (54.9%) maintained an overall positive attitude; however, the majority (58.6%) exhibited poor practices. The results indicated a statistically significant association between participants' knowledge and attitude levels, as well as between knowledge and practice levels (P <0.001). However, there was no statistically significant association between participants attitudes and practice levels (P = 0.815).
Conclusion: The study's findings revealed that slightly more than half of pharmacists had adequate fundamental knowledge of pharmacovigilance and ADR reporting and exhibited generally positive attitudes, yet gaps were evident in the practical application of ADR reporting practices. Additional training and education may still be necessary to gain a more profound understanding of the details of pharmacovigilance and enhance pharmacists’ engagement with ADR reporting.
Metrics
References
- Khardali A. Exploring the knowledge, perception, and practice of community pharmacists in Saudi Arabia toward pharmacovigilance and adverse drug reaction reporting: a nationwide survey. Sci Rep. 2024; 14(1):4819. https://doi.org/10.1038/s41598-024-55664-8.
- Abdulsalim S, Farooqui M, Alshammari MS, Alotaibi M, Alhazmi A, Alqasomi A, et al. Evaluation of knowledge, attitudes, and practices about pharmacovigilance among community pharmacists in Qassim, Saudi Arabia. Int J Environ Res Public Health. 2023; 20(4):3548. https://doi.org/10.3390/ijerph20043548.
- Sendekie AK, Kasahun AE, Limenh LW, Dagnaw AD, Belachew EA. Clinical and economic impact of adverse drug reactions in hospitalised patients: prospective matched nested case–control study in Ethiopia. BMJ Open. 2023; 13(6):e073777. https://doi.org/10.1136/bmjopen-2023-073777.
- Najafi S. Importance of pharmacovigilance and the role of healthcare professionals. J Pharmacovigil. 2018; 6(01):1-2. https://doi.org/10.4172/2329-6887.1000252.
- Kunduru V, Boggula N. A study on knowledge and awareness of community pharmacist towards ADR reporting. World J Pharm Pharm Sci. 2017; 6(4):1436-51. https://doi.org/10.20959/wjpps20174-8928.
- Mohammed SI, Al-Razaq AF. Knowledge and attitude of Iraqi pharmacists in Baghdad community toward adverse drug reactions monitoring. Asian J Pharm Clin Res. 2017; 10(4):219-22. http://dx.doi.org/10.22159/ajpcr.2017.v10i4.16595.
- Suyagh M, Farah D, Farha RA. Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Saudi Pharm J. 2015; 23(2):147-53. https://doi.org/10.1016/j.jsps.2014.07.001.
- Allela OQ, Shekhany NS, Shekhany BS. Adverse Drug Reactions (ADR’s) Reporting Barriers and Attitude among Pharmacists in Erbil, Kurdistan Region–Iraq. J Basic Clin Pharm. 2017; 8:S061.
- Alnawaiseh NA, AL-Oroud RY. Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working at Alkarak Governorate, Jordan. Biomed Pharmacol J. 2022; 15(2):967-78. https://dx.doi.org/10.13005/bpj/2432.
- Alwidyan T, Odeh M, Ibrahim AH, Harahsheh E, Banat A. Knowledge, attitude, and practice among community pharmacists toward adverse drug reaction reporting and pharmacovigilance: A nationwide survey. Explor Res Clin Soc Pharm. 2025; 18:100578. https://doi.org/10.1016/j.rcsop.2025.100578.
- AlWorafi YM, Hasan S, Hassan NM, Gaili AA. Knowledge, attitude and experience of pharmacist in the UAE towards pharmacovigilance. Res J Pharm Technol. 2021; 14(1):265-9. https://doi.org/10.5958/0974-360X.2021.00047.0.
- Alam K, Karki B, Gupta AK, Sarraf DP, Wagle S. Assessment of knowledge, attitude and practice of pharmacovigilance and adverse drug reactions reporting among the community pharmacies in Dharan. Int J Sci Rep. 2021; 7(8):382. https://dx.doi.org/10.18203/issn.2454-2156.IntJSciRep20212833.
- Hajj A, Hallit S, Ramia E, Salameh P, Order of Pharmacists Scientific Committee–Medication Safety Subcommittee. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon. Curr Med Res Opin. 2018; 34(1):149-56. https://doi.org/10.1080/03007995.2017.1361916.
- Alsheikh MY, Alasmari MM. A national survey of community pharmacists’ viewpoints about pharmacovigilance and adverse drug reaction reporting in Saudi Arabia. Front Pharmacol. 2022; 13:819551. https://doi.org/10.3389/fphar.2022.819551.
- Tolba MK, Abdel-Latif MM, Hassan SB. Pharmacists' knowledge and attitudes about ADRs reporting and pharmacovigilance practice in Egyptian hospitals. Bull Pharm Sci Assiut Univ. 2022; 45(2):869-82. https://doi.org/10.21608/bfsa.2022.271688.
- Shareef J, Sridhar SB, Bhupathyraaj M, Shariff A, Thomas S. Exploring the community pharmacist's knowledge, attitude, and practices regarding adverse drug reactions and its reporting in the United Arab Emirates: a survey-based cross-sectional study. Ther Adv Drug Saf. 2024; 15:1–21. https://doi.org/10.1177/20420986241285930.